Full Text View
Tabular View
No Study Results Posted
Related Studies
Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia
This study has been completed.
Study NCT00206960   Information provided by University of Copenhagen

First Received on September 10, 2005.   Last Updated on September 16, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
zuclopenthixol
risperidone
Additional drug interventions recognized in this trial
Antipsychotic Agents
Clopenthixol
Clopenthixol acetate ester
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Birte Glenthoj
University of Copenhagen
Glostrup University Hospital, Copenhagen
Rigshospitalet, Denmark
Hvidovre University Hospital
The Danish Medical Research Council
Copenhagen Hospital Corporation
Janssen-Cilag Ltd.
The Novo Nordic Foundation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services